Can AI help chest DDR achieve clinical adoption?
Chest dynamic digital radiography (DDR) may have received a boost toward clinical use in patients with lung disorders, with researchers developing AI to perform time-consuming analysis involved in the technology, according to researchers in New York City.
A group at Mount Sinai Hospital developed a “pipeline” of convolutional neural networks (CNNs) to analyze lung areas in DDR image sequences from patients. The model performed well enough to act as a surrogate to standard pulmonary function tests, they found.
“Our findings add to growing evidence suggesting DDR as a potential [pulmonary function test] surrogate,”...
Source: AuntMinnie.com Headlines - April 1, 2024 Category: Radiology Authors: Will Morton Tags: Digital X-Ray Artificial Intelligence Source Type: news
Removing Race Correction From Lung Function Test Changes Clinical Management
WEDNESDAY, Aug. 30, 2023 -- Removal of race correction from pulmonary function tests (PFTs) may change surgical management of lung cancer in African American patients, according to a study published Aug. 16 in JAMA Surgery.
Sidra N. Bonner, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 30, 2023 Category: Pharmaceuticals Source Type: news
How Race-Neutral Equations for Pulmonary Testing Affect Patients
(MedPage Today) -- The use of newly developed race-neutral reference equations for pulmonary function test (PFT) interpretation led to a significant increase in both the prevalence and severity of respiratory impairments among Black patients compared... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 2, 2023 Category: American Health Source Type: news
Black Patients May Be Underdiagnosed for Lung Problems Because of Software Bias
This study, published in JAMA Network Open, offers one of the first real-world examples of how the the issue may affect diagnosis and care for lung patients, said Dr. Darshali Vyas, a pulmonary care doctor at Massachusetts General Hospital.
[time-brightcove not-tgx=”true”]
The results are “exciting” to see published but it’s also “what we’d expect” from setting aside race-based calculations, said Vyas, who was an author of an influential 2020 New England Journal of Medicine article that catalogued examples of how race-based assumptions are used in making doctors’ decisi...
Source: TIME: Health - June 2, 2023 Category: Consumer Health News Authors: Mike Stobbe/AP Tags: Uncategorized healthscienceclimate Research wire Source Type: news
U.S. FDA grants priority review to Roche ’s Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults
If approved,Actemra/RoActemra would be the first U.S. FDA-approvedimmunomodulator for the treatment of COVID-19 inhospitalised patientsSince the beginning of the pandemic, more than one million peoplehospitalised with COVID-19 have been treated withActemra/RoActemra worldwide1Actemra/RoActemra is approved for the treatment of COVID-19 in many territories including the European UnionRoche has established a comprehensive access approach to improve availability ofActemra/RoActemra around the worldBasel, 04 April 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has acce...
Source: Roche Investor Update - April 4, 2022 Category: Pharmaceuticals Source Type: news
U.S. FDA grants priority review to Roche ’s Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults
If approved,Actemra/RoActemra would be the first U.S. FDA-approvedimmunomodulator for the treatment of COVID-19 inhospitalised patientsSince the beginning of the pandemic, more than one million peoplehospitalised with COVID-19 have been treated withActemra/RoActemra worldwide1Actemra/RoActemra is approved for the treatment of COVID-19 in many territories including the European UnionRoche has established a comprehensive access approach to improve availability ofActemra/RoActemra around the worldBasel, 04 April 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has acce...
Source: Roche Media News - April 4, 2022 Category: Pharmaceuticals Source Type: news
Removal of 'race correction' in pulmonary function tests highlights health disparity
(American Thoracic Society) By removing " race correction " from the interpretation of pulmonary function test (PFT) results, Black individuals were shown to have a significantly higher prevalence and severity of lung disease, according to research presented at the ATS 2021 International Conference. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 16, 2021 Category: International Medicine & Public Health Source Type: news
Evidence check: the medium and long-term sequelae of COVID-19, New South Wales Government COVID-19 Critical Intelligence Unit
Rapid review question: What are the medium- and long-term health sequelae of COVID-19 infection among survivors? In brief: General health sequelae • Symptoms commonly reported among recovered COVID-19 patients two to eight weeks after the onset of symptoms (or a positive COVID-19 test) include: fatigue, shortness of breath, muscle or joint pain, chest pain, cough, and insomnia and/or sleep disorders.(1-6) • A study of 202 confirmed COVID -19 patients with mild symptoms, found altered sense of smell or taste occurred in 18.6% of patients, feelings of being tired in 13.1%, problems breathing in 10.4% and muscle or joint...
Source: Current Awareness Service for Health (CASH) - September 17, 2020 Category: Consumer Health News Source Type: news
How Is a Pulmonary Function Test Performed?
Title: How Is a Pulmonary Function Test Performed?Category: Procedures and TestsCreated: 7/15/2020 12:00:00 AMLast Editorial Review: 7/15/2020 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - July 15, 2020 Category: Respiratory Medicine Source Type: news
Roche launches new blood gas digital solution designed to improve patient care
Basel, 15 May 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE mark availability of Roche v-TAC, a new digital diagnostic solution that allows clinicians to obtain results for arterial blood gas values from patients with respiratory or metabolic abnormalities via a simpler, less invasive venous puncture through the use of a digital algorithm. Blood gas analysis is typically used in hospital point of care (POC) settings, where quick and accurate results are needed. This includes emergency rooms, intensive care units and operating rooms. The analysis provides clinicians with information about a patient ’s p...
Source: Roche Investor Update - May 15, 2020 Category: Pharmaceuticals Source Type: news
Roche launches new blood gas digital solution designed to improve patient care
Basel, 15 May 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE mark availability of Roche v-TAC, a new digital diagnostic solution that allows clinicians to obtain results for arterial blood gas values from patients with respiratory or metabolic abnormalities via a simpler, less invasive venous puncture through the use of a digital algorithm. Blood gas analysis is typically used in hospital point of care (POC) settings, where quick and accurate results are needed. This includes emergency rooms, intensive care units and operating rooms. The analysis provides clinicians with information about a patient ’s p...
Source: Roche Media News - May 15, 2020 Category: Pharmaceuticals Source Type: news
Are Your Lungs at Risk?
As our national lockdown drags on, the media repeats the same message…
Isolation is the only solution.
You must stay home, avoid other people, stay away from your office, give up on recreation and socializing…
But maybe there’s a different way to handle this.
Throughout my career — and especially here at the Sears Institute for Anti-Aging Medicine — I’ve sought to make my patients, employees, and readers healthier, more vital, and more resistant to disease.
Few people are talking about why this virus is mostly a threat to elders or people who already have a disease diagnosis.
Truth is, almost all th...
Source: Al Sears, MD Natural Remedies - May 8, 2020 Category: Complementary Medicine Authors: Dr.A.Sears Tags: Fitness Health Source Type: news
Gala Therapeutics launches RheOx chronic bronchitis trial
Gala Therapeutics said today that it launched an early feasibility study of its RheOx system for treating chronic bronchitis, and that the first two patients in the trial have already been enrolled.
Initial patient enrollment took place at the University of Pittsburgh Medical Center, with RheOx bronchial rheoplasty procedures performed by Dr. Frank Sciurba and Roy Semaan, the Menlo Park, Calif.-based company said.
“We are pleased to partner with Gala in treating the first US patients and thus continuing the contribution of UPMC as a leader in the development of novel devices for our patients with COPD. RheOx offers ...
Source: Mass Device - November 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Respiratory galatherapeutics Source Type: news
How a New Emphysema Device Won FDA Approval in Six Months
FDA has approved a new device intended to treat breathing difficulty associated with severe emphysema. The approval comes just two weeks after an FDA advisory panel shot down a competing technology targeting the same patient population.
The agency approved Pulmonx Inc.'s Zephyr endobronchial valve through the breakthrough device designation, a pathway reserved for devices that provide for more effective treatment or diagnosis of a life-threatening or irreversibly debilitating disease or condition. Devices also must meet one of the following criteria: the device must represent a breakthrough technology; there must be no app...
Source: MDDI - July 2, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news
Reference Equations for Spirometric Indices Reference Equations for Spirometric Indices
Spirometric measurements from a sample of adult Nigerians provides updated reference data for interpreting pulmonary function test results.BMC Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 31, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news
